APA (7th ed.) Citation

BS, T., F, P., R, K., J, W., Y, S., J, G., & L, S. (2024). Risk of post-injection endophthalmitis peaks within the first three injections of anti-vascular endothelial growth factor therapy: A nationwide registry-based study. Acta ophthalmologica, 102(8), 953. https://doi.org/10.1111/aos.16727

Chicago Style (17th ed.) Citation

BS, Thinggaard, Pedersen F, Kawasaki R, Wied J, Subhi Y, Grauslund J, and Stokholm L. "Risk of Post-injection Endophthalmitis Peaks Within the First Three Injections of Anti-vascular Endothelial Growth Factor Therapy: A Nationwide Registry-based Study." Acta Ophthalmologica 102, no. 8 (2024): 953. https://doi.org/10.1111/aos.16727.

MLA (9th ed.) Citation

BS, Thinggaard, et al. "Risk of Post-injection Endophthalmitis Peaks Within the First Three Injections of Anti-vascular Endothelial Growth Factor Therapy: A Nationwide Registry-based Study." Acta Ophthalmologica, vol. 102, no. 8, 2024, p. 953, https://doi.org/10.1111/aos.16727.